Mohamed Allam - Academia.edu (original) (raw)
Papers by Mohamed Allam
Egyptian Journal of Pediatric Allergy and Immunology, 2009
Medicina General y de Familia, 2015
Journal of exploratory research in pharmacology, Jul 4, 2023
Journal of preventive medicine and hygiene, 2011
In the primitive societies dancing was as essential as eat-ing or sleeping. Dancing was the mode ... more In the primitive societies dancing was as essential as eat-ing or sleeping. Dancing was the mode of individual and group expression, and communication with others or even with the nature. The major changes over the history were accompanied with changes in the dancing rituals of every society [1].According to Keogh and collaborators (2009) dancing is a mode of physical activity that may allow people to im-prove their physical function, health, and well-being [2]. Recent study in Greece evaluated the effect of a tradi-tional dance training program on aerobic capacity and muscle strength of adults with hearing loss. The results of this intervention study, following 12-week training program, showed significant improvements in peak physiological parameters for peak minute ventilation, peak oxygen consumption (both absolute and relative), time to exhaustion, and peak torque values between the 2 measurements (initial and final). The authors concluded that adults with hearing loss can impro...
Research Square (Research Square), Jun 13, 2023
Trends Journal of Sciences Research
World Journal of Medical Microbiology, Sep 18, 2023
World Journal of Medical Microbiology, Sep 18, 2023
Cancer Causes & Control, May 30, 2019
Background Inconsistent results for coffee consumption and bladder cancer (BC) risk have been sho... more Background Inconsistent results for coffee consumption and bladder cancer (BC) risk have been shown in epidemiological studies. This research aims to increase the understanding of the association between coffee consumption and BC risk by bringing together worldwide case-control studies on this topic. Methods Data were collected from 13 case-control comprising of 5,911 cases and 16,172 controls. Pooled multivariate odds ratios (ORs), with corresponding 95% confidence intervals (CIs), were obtained using multilevel logistic regression models. Furthermore, linear dose-response relationships were examined using fractional polynomial models. Results No association of BC risk was observed with coffee consumption among smokers. However, after adjustment for age, gender, and smoking, the risk was significantly increased for never smokers (ever vs. never coffee consumers: OR model2 1.30, 95% CI 1.06-1.59; heavy (> 4 cups/day) coffee consumers vs. never coffee consumers: OR model2 1.52, 95% CI 1.18-1.97, p trend = 0.23). In addition, dose-response analyses, in both the overall population and among never smokers, also showed a significant increased BC risk for coffee consumption of more than four cups per day. Among smokers, a significant increased BC risk was shown only after consumption of more than six cups per day. Conclusion This research suggests that positive associations between coffee consumption and BC among never smokers but not smokers.
The Egyptian Journal of Hospital Medicine, 2023
European journal of clinical medicine, May 17, 2024
European journal of medical and health sciences, Apr 4, 2024
Current research in public health, Mar 5, 2024
Global journal of medical case reports, Oct 9, 2023
Trends Journal of Sciences Research
Many attempts have been made to repurpose existing and approved drugs for the treatment of COVID-... more Many attempts have been made to repurpose existing and approved drugs for the treatment of COVID-19 infection. This involves anti-malarial drugs such as hydroxychloroquine and chloroquine, which have been shown to be less successful than initially believed, with a substantial risk of often fatal complications and interactions. This also involves Remdesivir, which has been shown to decrease recovery time significantly in hospitalized patients. However, for patients who are not yet hospitalized, there is no currently accepted treatment. Treating patients before they need to be admitted or even prophylactically could greatly decrease the load on hospitals, protect healthcare workers and reduce the spread of COVID-19. An in-vitro study indicated that Ivermectin was dynamic against COVID-19-infected cell. Ivermectin has antimicrobial, antiviral, and anticancer, immunomodulatory properties. This drug could reduce the viral load in COVID-9 infected patients, with potential effect on disease progression and spread. Therefore, Ivermectin may be a therapeutic choice for treatment of COVID-19, however, there is still a lack of evidence-based studies to support ivermectin treatment of patients with COVID-19.
Trends Journal of Sciences Research
Egyptian Journal of Pediatric Allergy and Immunology, 2009
Medicina General y de Familia, 2015
Journal of exploratory research in pharmacology, Jul 4, 2023
Journal of preventive medicine and hygiene, 2011
In the primitive societies dancing was as essential as eat-ing or sleeping. Dancing was the mode ... more In the primitive societies dancing was as essential as eat-ing or sleeping. Dancing was the mode of individual and group expression, and communication with others or even with the nature. The major changes over the history were accompanied with changes in the dancing rituals of every society [1].According to Keogh and collaborators (2009) dancing is a mode of physical activity that may allow people to im-prove their physical function, health, and well-being [2]. Recent study in Greece evaluated the effect of a tradi-tional dance training program on aerobic capacity and muscle strength of adults with hearing loss. The results of this intervention study, following 12-week training program, showed significant improvements in peak physiological parameters for peak minute ventilation, peak oxygen consumption (both absolute and relative), time to exhaustion, and peak torque values between the 2 measurements (initial and final). The authors concluded that adults with hearing loss can impro...
Research Square (Research Square), Jun 13, 2023
Trends Journal of Sciences Research
World Journal of Medical Microbiology, Sep 18, 2023
World Journal of Medical Microbiology, Sep 18, 2023
Cancer Causes & Control, May 30, 2019
Background Inconsistent results for coffee consumption and bladder cancer (BC) risk have been sho... more Background Inconsistent results for coffee consumption and bladder cancer (BC) risk have been shown in epidemiological studies. This research aims to increase the understanding of the association between coffee consumption and BC risk by bringing together worldwide case-control studies on this topic. Methods Data were collected from 13 case-control comprising of 5,911 cases and 16,172 controls. Pooled multivariate odds ratios (ORs), with corresponding 95% confidence intervals (CIs), were obtained using multilevel logistic regression models. Furthermore, linear dose-response relationships were examined using fractional polynomial models. Results No association of BC risk was observed with coffee consumption among smokers. However, after adjustment for age, gender, and smoking, the risk was significantly increased for never smokers (ever vs. never coffee consumers: OR model2 1.30, 95% CI 1.06-1.59; heavy (> 4 cups/day) coffee consumers vs. never coffee consumers: OR model2 1.52, 95% CI 1.18-1.97, p trend = 0.23). In addition, dose-response analyses, in both the overall population and among never smokers, also showed a significant increased BC risk for coffee consumption of more than four cups per day. Among smokers, a significant increased BC risk was shown only after consumption of more than six cups per day. Conclusion This research suggests that positive associations between coffee consumption and BC among never smokers but not smokers.
The Egyptian Journal of Hospital Medicine, 2023
European journal of clinical medicine, May 17, 2024
European journal of medical and health sciences, Apr 4, 2024
Current research in public health, Mar 5, 2024
Global journal of medical case reports, Oct 9, 2023
Trends Journal of Sciences Research
Many attempts have been made to repurpose existing and approved drugs for the treatment of COVID-... more Many attempts have been made to repurpose existing and approved drugs for the treatment of COVID-19 infection. This involves anti-malarial drugs such as hydroxychloroquine and chloroquine, which have been shown to be less successful than initially believed, with a substantial risk of often fatal complications and interactions. This also involves Remdesivir, which has been shown to decrease recovery time significantly in hospitalized patients. However, for patients who are not yet hospitalized, there is no currently accepted treatment. Treating patients before they need to be admitted or even prophylactically could greatly decrease the load on hospitals, protect healthcare workers and reduce the spread of COVID-19. An in-vitro study indicated that Ivermectin was dynamic against COVID-19-infected cell. Ivermectin has antimicrobial, antiviral, and anticancer, immunomodulatory properties. This drug could reduce the viral load in COVID-9 infected patients, with potential effect on disease progression and spread. Therefore, Ivermectin may be a therapeutic choice for treatment of COVID-19, however, there is still a lack of evidence-based studies to support ivermectin treatment of patients with COVID-19.
Trends Journal of Sciences Research